Keyphrases
Aberrant Phenotype
100%
Leukaemic Cells
100%
CD19
50%
CD20
37%
CD10
37%
Immunophenotyping
25%
Cell Control
25%
CD45 Antigen
25%
Normal B Cells
25%
Acute Lymphoblastic Leukemia Cells
25%
CD20 Antigen
25%
CD10 Antigen
25%
Bone Marrow Samples
12%
High Cell Viability
12%
Absolute Cell Count
12%
Proliferation Index
12%
Cell Maintenance
12%
CFSE Labeling
12%
CD19 Antigen
12%
Lymphoid Cells
12%
B Cell Subpopulations
12%
Leukemia Patients
12%
Patient Cells
12%
Mononuclear Cells
12%
B-cell Precursors
12%
Cell Population
12%
Body Donation
12%
Medicine and Dentistry
Mesenchymal Stem Cell
100%
Acute B-Cell Lymphoblastic Leukemia
100%
Bone Marrow Mesenchymal Stem Cell
100%
Acute Lymphoblastic Leukemia
62%
CD20
37%
Common Acute Lymphoblastic Leukemia Antigen
25%
Receptor Type Tyrosine Protein Phosphatase C
25%
CD20 Antigen
25%
Immunophenotyping
25%
B Cell
12%
B Lymphocyte Subpopulation
12%
Flow Cytometry
12%
Precursor
12%
Cell Count
12%
Carboxyfluorescein Diacetate Succinimidyl Ester
12%
Cell Population
12%
Mononuclear Cell
12%
CD19 Antigen
12%
Lymphoid Cell
12%
Cell Viability
12%
Immunology and Microbiology
B Cell
100%
Mesenchymal Stem Cell
100%
CD19
44%
Coculture
33%
CD20
33%
Receptor Type Tyrosine Protein Phosphatase C
22%
CD20 Antigen
22%
Common Acute Lymphoblastic Leukemia Antigen
22%
Leukemia Cell
22%
Innate Lymphoid Cell
11%
Cell Population
11%
Cell Viability
11%
Precursor
11%
B Lymphocyte Subpopulation
11%
CD19 Antigen
11%
Mononuclear Cell
11%
Cell Count
11%
Veterinary Science and Veterinary Medicine
Acute B-Cell Lymphoblastic Leukemia
100%
Acute Lymphocytic Leukemia
55%
Receptor Type Tyrosine Protein Phosphatase C
11%
INIS
lymphoid cells
11%
labelling
11%